If it's in the News, it's in our Polls. Public opinion polling since 2003.


Poll: 66% Believe Stem Cell Research May Lead to Cures

On Wednesday, President Bush is prepared to veto stem cell research legislation, the second time he has used the veto pen for that purpose. A Rasmussen Reports survey conducted earlier this year found that 66% of Americans believe that “embryonic stem cell research" is at least somewhat likely to lead to cures to previously incurable diseases. This figure includes 72% of Democrats, 59% of Republicans, and 69% of those not affiliated with either major political party. Americans under 30 were a bit more optimistic than their elders about the potential of such research.

Want to read more?

Become a Rasmussen Reader to read the article

Have an account?

Log In

Become a Reader


Rasmussen Reports is a media company specializing in the collection, publication and distribution of public opinion information.

We conduct public opinion polls on a variety of topics to inform our audience on events in the news and other topics of interest. To ensure editorial control and independence, we pay for the polls ourselves and generate revenue through the sale of subscriptions, sponsorships, and advertising. Nightly polling on politics, business and lifestyle topics provides the content to update the Rasmussen Reports web site many times each day. If it's in the news, it's in our polls. Additionally, the data drives a daily update newsletter and various media outlets across the country.

Some information, including the Rasmussen Reports daily Presidential Tracking Poll and commentaries are available for free to the general public. Subscriptions are available for $4.95 a month or 34.95 a year that provide subscribers with exclusive access to more than 20 stories per week on upcoming elections, consumer confidence, and issues that affect us all. For those who are really into the numbers, Platinum Members can review demographic crosstabs and a full history of our data.

To learn more about our methodology, click here.